Implications of Genomic and Genetic Testing for the Management of Prostate Cancer Patients | OncologyPRO
ESMO E-Learning: Implications of Genomic and Genetic Testing for the Management of Prostate Cancer Patients
Related Articles
ESMO Welcomes the Adoption of a Research Friendly European Health Data Space (EHDS) Regulation by the European Parliament’s Plenary
The EHDS can contribute to boosting cancer research by facilitating the (re)use of existing data sources – in anonymised or pseudorandomised format
ESMO Courses in Medical Oncology for Medical Students
The Medical Oncology Course for Students will take place in Naples and Valencia in 2019
Real World Data and Digital Oncology – Digital Health as Cancer C
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Editor-in-Chief Of ESMO Rare Cancers, a New, Online, Open Access Journal from ESMO
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
YO4YO Virtual Session Series
This live web event series, powered by Young Oncologists for Young Oncologists, consists of highly interactive career and professional development…
Precision Oncology: Genomics Guided Care – Taxonomy and Framework for Development of Tumour-Agnostic Precision Therapeutics 2024
Precision Oncology: Genomics Guided Care – Taxonomy and Framework for Development of Tumour-Agnostic Precision Therapeutics 2024Chair: Benedikt WestphalenCo-Chair: George PentheroudakisSpeakers: Claudia Cardone, Vivek Subbiah, Sewanti Limaye